The Potential Dangers of Using MDMA for Psychotherapy (Q21558619)

PubMed

PubMed publication ID

24830184

Journal of Psychoactive Drugs

6 February 2023

language of work or name

English

0 references

publication date

January 2014

0 references

published in

0 references

volume

46

0 references

issue

1

0 references

page(s)

37-43

0 references

cites work

Does cigarette smoking cause stress?

1 reference

https://api.crossref.org/works/10.1080/02791072.2014.873690

Brain serotonin function in MDMA (ecstasy) users: evidence for persisting neurotoxicity

20 April 2017

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

Prospective associations between meth/amphetamine (speed) and MDMA (ecstasy) use and depressive symptoms in secondary school students

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): a stressor on the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

Neuroimaging research in human MDMA users: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

Empathy and aggression: two faces of ecstasy? A study of interpretative cognitive bias and mood change in ecstasy users

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

A Clinical Plan for MDMA (Ecstasy) in the Treatment of Posttraumatic Stress Disorder (PTSD): Partnering with the FDA

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

Subjective reports of the effects of MDMA in a clinical setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

Gender differences in the subjective effects of MDMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

Decreased pain tolerance and mood in recreational users of MDMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

MDMA (3,4-Methylenedioxymethamphetamine) or ecstasy: the neuropsychobiological implications of taking it at dances and raves

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

The psychotherapeutic potential of MDMA (3,4-methylenedioxymethamphetamine): an evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

Cortisol and 3,4-methylenedioxymethamphetamine: neurohormonal aspects of bioenergetic stress in ecstasy users

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

MDMA and 5-HT neurotoxicity: the empirical evidence for its adverse effects in humans - no need for translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational 'Ecstasy' users

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

Human psychobiology of MDMA or 'Ecstasy': an overview of 25 years of empirical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

MDMA and methamphetamine: some paradoxical negative and positive mood changes in an acute dose laboratory study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

Increased cortisol levels in hair of recent Ecstasy/MDMA users

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

Hug drug or thug drug? Ecstasy use and aggressive behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

Differential experiences of the psychobiological sequelae of ecstasy use: quantitative and qualitative data from an internet study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

Patterns of drug use and the influence of gender on self-reports of memory ability in ecstasy users: a web-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

Symptomatological features of patients with and without Ecstasy use during their first psychotic episode

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

Potential human neurotoxicity of MDMA ('Ecstasy'): subjective self-reports, evidence from an Italian drug addiction centre and clinical case studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

Hair MDMA samples are consistent with reported ecstasy use: findings from a study investigating effects of ecstasy on mood and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

The background and chemistry of MDMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

Psychiatric disorders in Ecstasy (MDMA) users: a literature review focusing on personal predisposition and drug history

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

Quitting ecstasy: an investigation of why people stop taking the drug and their subsequent mental health

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

Cognitive performance and serotonergic function in users of ecstasy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naïve healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

Working memory deficits in current and previous users of MDMA ('ecstasy').

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690

Ecstasy use in Australia: patterns of use and associated harm

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2014.873690